These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation. Huang D; Wang S; Wang A; Chen X; Zhang H Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):788-94. PubMed ID: 27521796 [TBL] [Abstract][Full Text] [Related]
3. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness. Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038 [TBL] [Abstract][Full Text] [Related]
4. Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules. Zhu T; Li X; Luo L; Wang X; Li Z; Xie P; Gao X; Song Z; Su J; Liang G J Transl Med; 2015 Nov; 13():356. PubMed ID: 26563263 [TBL] [Abstract][Full Text] [Related]
5. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. Jiang X; Yan Y; Hu M; Chen X; Wang Y; Dai Y; Wu D; Wang Y; Zhuang Z; Xia H J Neurosurg; 2016 Jan; 124(1):129-36. PubMed ID: 26274999 [TBL] [Abstract][Full Text] [Related]
6. GOLPH3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro. Zhang X; Ding Z; Mo J; Sang B; Shi Q; Hu J; Xie S; Zhan W; Lu D; Yang M; Bian W; Zhou X; Yu R Mol Carcinog; 2015 Nov; 54(11):1252-63. PubMed ID: 25156912 [TBL] [Abstract][Full Text] [Related]
7. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287 [TBL] [Abstract][Full Text] [Related]
8. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma. Kaur H; Ali SZ; Huey L; Hütt-Cabezas M; Taylor I; Mao XG; Weingart M; Chu Q; Rodriguez FJ; Eberhart CG; Raabe EH Cancer Lett; 2016 Jul; 377(1):55-64. PubMed ID: 27102002 [TBL] [Abstract][Full Text] [Related]
9. Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells. Jung EH; Lee HN; Han GY; Kim MJ; Kim CW Cell Biochem Funct; 2016 Apr; 34(3):149-57. PubMed ID: 26923195 [TBL] [Abstract][Full Text] [Related]
10. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078 [TBL] [Abstract][Full Text] [Related]
11. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma. Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287 [TBL] [Abstract][Full Text] [Related]
12. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling. Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169 [TBL] [Abstract][Full Text] [Related]
13. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491 [TBL] [Abstract][Full Text] [Related]
14. Let-7g-5p inhibits epithelial-mesenchymal transition consistent with reduction of glioma stem cell phenotypes by targeting VSIG4 in glioblastoma. Zhang XH; Qian Y; Li Z; Zhang NN; Xie YJ Oncol Rep; 2016 Nov; 36(5):2967-2975. PubMed ID: 27634309 [TBL] [Abstract][Full Text] [Related]
15. Girdin, an actin-binding protein, is critical for migration, adhesion, and invasion of human glioblastoma cells. Gu F; Wang L; He J; Liu X; Zhang H; Li W; Fu L; Ma Y J Neurochem; 2014 Nov; 131(4):457-69. PubMed ID: 25060559 [TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma. Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473 [TBL] [Abstract][Full Text] [Related]
18. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness. Lemke D; Pfenning PN; Sahm F; Klein AC; Kempf T; Warnken U; Schnölzer M; Tudoran R; Weller M; Platten M; Wick W Clin Cancer Res; 2012 Jan; 18(1):105-17. PubMed ID: 22080438 [TBL] [Abstract][Full Text] [Related]
19. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation. Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097 [TBL] [Abstract][Full Text] [Related]
20. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Galavotti S; Bartesaghi S; Faccenda D; Shaked-Rabi M; Sanzone S; McEvoy A; Dinsdale D; Condorelli F; Brandner S; Campanella M; Grose R; Jones C; Salomoni P Oncogene; 2013 Feb; 32(6):699-712. PubMed ID: 22525272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]